Back
Monte Rosa Therapeutics Stock Price Chart
Trump's Legacy-Defining Momentor Strike
But the Surprising Way Trump Solves it Could Cement His Legacy.
Sell
21
GLUE
Monte Rosa Therapeutics
Last Price:
$6.92
Seasonality Move:
-3.94%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLUE is experiencing slight buying pressure.
Monte Rosa Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.46 | Sell |
| 20-day SMA: | 8.59 | Sell |
| 50-day SMA: | 7.94 | Sell |
| 200-day SMA: | 5.93 | Buy |
| 8-day EMA: | 7.49 | Sell |
| 20-day EMA: | 8.11 | Sell |
| 50-day EMA: | 7.84 | Sell |
| 200-day EMA: | 6.37 | Buy |
Monte Rosa Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.34 | Sell |
| Relative Strength Index (14 RSI): | 39.42 | Sell |
| Chaikin Money Flow: | 968460 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.45 - 9.53) | Sell |
| Bollinger Bands (100): | (4.82 - 8.52) | Buy |
Monte Rosa Therapeutics Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monte Rosa Therapeutics Stock
Is Monte Rosa Therapeutics Stock a Buy?
-
Monte Rosa Therapeutics share price is 6.91 while GLUE 8-day simple moving average is 7.46, which is a Sell signal.
-
The stock price of GLUE is 6.91 while Monte Rosa Therapeutics 20-day SMA is 8.59, which makes it a Sell.
-
Monte Rosa Therapeutics 50-day simple moving average is 7.94 while GLUE share price is 6.91, making it a Sell technically.
-
GLUE stock price is 6.91 and Monte Rosa Therapeutics 200-day simple moving average is 5.93, creating a Buy signal.
GLUE Technical Analysis vs Fundamental Analysis
Sell
21
Monte Rosa Therapeutics (GLUE)
is a Sell
Is Monte Rosa Therapeutics a Buy or a Sell?
-
Monte Rosa Therapeutics stock is rated a SellThe current Monte Rosa Therapeutics [GLUE] share price is $6.91. The Score for GLUE is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
Monte Rosa Therapeutics Stock Info
Market Cap:
424.5M
Price in USD:
6.91
Share Volume:
2.6M
Monte Rosa Therapeutics 52-Week Range
52-Week High:
12.40
52-Week Low:
3.21
Sell
21
Monte Rosa Therapeutics (GLUE)
is a Sell
Monte Rosa Therapeutics Share Price Forecast
-
What is the Monte Rosa Therapeutics stock price today?The Monte Rosa Therapeutics stock price is 6.91 USD today.
-
Will GLUE stock go up or go down?Monte Rosa Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Monte Rosa Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monte Rosa Therapeutics is overvalued.
Is Monte Rosa Therapeutics Stock a Buy?
-
Monte Rosa Therapeutics share price is 6.91 while GLUE 8-day exponential moving average is 7.49, which is a Sell signal.
-
The stock price of GLUE is 6.91 while Monte Rosa Therapeutics 20-day EMA is 8.11, which makes it a Sell.
-
Monte Rosa Therapeutics 50-day exponential moving average is 7.84 while GLUE share price is 6.91, making it a Sell technically.
-
GLUE stock price is 6.91 and Monte Rosa Therapeutics 200-day simple moving average is 6.37, creating a Buy signal.
Fundamental Analysis of Monte Rosa Therapeutics
Is Monte Rosa Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and a decrease next year of $0.60 per share.
Technical Analysis of Monte Rosa Therapeutics
Should I short Monte Rosa Therapeutics stock?
-
GLUE Moving Average Covergence Divergence (MACD) indicator is -0.34, suggesting Monte Rosa Therapeutics is a Sell
-
Monte Rosa Therapeutics Relative Strength Index (RSI) is 39.42, which suggest Monte Rosa Therapeutics is oversold
-
The Bollinger Bands (25) for Monte Rosa Therapeutics is (7.45 - 9.53), which suggest Monte Rosa Therapeutics is a Buy
-
The Bollinger Bands (100) for Monte Rosa Therapeutics is (4.82 - 8.52), which suggest Monte Rosa Therapeutics is a Buy
* Monte Rosa Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.